TrialBMC pulmonary medicine2020

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.

James F Donohue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.